Allison W. Kurian offers insight on using multigene panel testing to discover breast and ovarian cancer risks that may have otherwise went undetected. Multigene panel sequencing detected ovarian ...

A 10-year study shows that a multipronged approach using whole exome sequencing can improve diagnostic yield in patients with ...

Please provide your email address to receive an email when new articles are posted on . A kidney disease panel for 382 genes yielded a high success rate and was effective in identifying monogenic ...

Choosing the right Telegram growth provider has become more complex as the market fills with panels promising fast results but delivering inconsistent performance. When users search how to choose ...

The U.S. Preventive Services Task Force has endorsed self-testing as a viable option for cervical cancer screening in an effort to make testing more accessible and reduce cancer rates nationwide. The ...

San Francisco, USA, Jan. 16, 2026 (GLOBE NEWSWIRE) -- The Pan-Genomic and Multi-Gene Panel Testing Market reached a valuation of US$ 8,907.34 million in 2024 and is projected to grow steadily over the ...

Wisdom Panel on Wednesday announced a new breed detection system for its BCSYS dog DNA test kits. BCSYS, which stands for Breed Classification System, offers "the most accurate and comprehensive ...

HELOISE: Phase IIIb Randomized Multicenter Study Comparing Standard-of-Care and Higher-Dose Trastuzumab Regimens Combined With Chemotherapy as First-Line Therapy in Patients With Human Epidermal ...

Panel testing for genetic variants linked to more cancers is cost-effective than just testing or BRCA1/2 mutations, says a clinical director for a women's health company. If caught early, the survival ...

A federal drug testing advisory board will begin discussions next month on possibly adding a testing panel for fentanyl to drug test drivers and other federal safety-sensitive employees for the ...

We conducted a retrospective database analysis using medical and pharmacy claims data. Medicare Advantage Prescription Drug Plan members diagnosed with select malignant solid tumors were identified.